133 results on '"Duckert F"'
Search Results
2. Factor VII clotting activity
3. Work-related drinking and processes of social integration and marginalization in two Norwegian workplaces
4. 2.1. Comparison of Six Different Methods for the Quantitative Assay of Antithrombin III (in English)
5. LUNG AND COAGULATION
6. Urokinase
7. 4.5. The quantitative determination of urokinase with Chromozym UK (in English)
8. C. Blood Coagulation and Fibrinolysis
9. Contributors
10. Discussion
11. II. Podiumsgespräch
12. Quantitative Bestimmungen von Faktor VIII (antihämophilem Globulin) und Faktor IX (Christmas Factor, PTC) bei Blutersippen
13. Quantitative Bestimmungen von Faktor VIII (antihämophilem Globulin) und Faktor IX (Christmas Factor, PTC) bei Blutersippen
14. The Therapy of Factor XIII Deficiency
15. Haemostasis Factors in Angina Pectoris; Relation to Gender, Age and Acute-phase Reaction
16. The development of alcoholics' and heavy drinkers' consumption: a longitudinal study.
17. Anticardiolipin antibodies and coronary heart disease
18. Factor XIII
19. What happens to drinking after therapeutic intervention?
20. The Impact of Sequential Quality Assessment Exercises on Laboratory Performance: The Multicentre ECAT Angina Pectoris
21. Patterns of contact phase proteins indicating neuropathy in diabetic patients
22. Biochemie der Blutgerinnung und Fibrinolyse. Von Irene Witt. Verlag Chemie GmbH, Weinheim 1975. 1. Aufl., 150 S., 30 Abb., 14 Tab., geb. DM 42,–
23. Interaction study between phenprocoumon and flurbiprofen
24. Rehabilitation of alcoholics and drug addicts; an experimental approach.
25. Side Effects of Thrombolytic Treatment with Porcine Plasmin and Low Dose Streptokinase
26. PREVENTION OF POSTOPERATIVE THROMBOEMBOLISM BY DEXTRAN 40, LOW DOSES OF HEPARIN, OR XANTINOL NICOTINATE
27. The influence of dimethylbiguanide on phenprocoumon elimination and its mode of action
28. LOW-DOSE HEPARIN
29. Heparin Cofactor II Determination - Levels in Normals and Patients with Hereditary Antithrombin III Deficiency and Disseminated Intravascular Coagulation
30. Heparin-Kofaktor II
31. The Contact Phase of Blood Coagulation in Diabetes Mellitus and in Patients with Vasculopathy
32. Quantitative Estimation of Coagulation Factors in Liver Disease. The Diagnostic and Prognostic Value of Factor XIII, Factor V and Plasminogen
33. Plasmin Inhibitors and Fibrinogen Breakdown During the Initial Phase of Thrombolytic Treatment - The Problem of the α2-Antiplasmin Determination
34. Preparation of Factor VIII-Free Plasma by Immunoaffinity Chromatography on Insolubilized Antibodies against Factor VIII-Related Antigen
35. LONG-TERM MORBIDITY AFTER DEEP VEIN THROMBOSIS (DVT)
36. Dissociation of Factor VIII Procoagulant Antigen VIII : CAg and Factor VIII Related Antigen VIIIR : Ag by EDTA - Influence of Divalent Cation on the Binding of VIII: CAg and VIIIR :Ag
37. Sequential Treatment of Deep Leg Vein Thrombosis with Porcine Plasmin and Low Dose Streptokinase
38. Fifteen Coagulation and Fibrinolysis Parameters in Diabetes Mellitus and in Patients with Vasculopathy
39. In Vitro Effects of the Acylated StreptokinasePlasminogen Activator Complex BRL 33 575 Incubated with Normal Human Plasma
40. Impaired Fibrinolysis as an Essential Contribution to Thrombosis in Patients with Lupus Anticoagulant
41. Reactivity of a Hereditary Abnormal Antithrombin III Fraction in the Inhibition of Thrombin and Factor Xa
42. Bestimmung der Thromboplastinzeit mit einem neuen standardisierten Thromboplastin aus menschlicher Plazenta: Ergebnisse einer kooperativen Studie
43. Fibrinogen, Factor VIII Related Antigen, Antithrombin III and α2-Antiplasmin in Peripheral Arterial Disease
44. Ethanol elimination-rates determined by breath analysis as a marker of recent excessive ethanol consumption
45. The Determination of Antithrombin III
46. FACTOR XII, PLASMA PREKALLIKREIN ,α2-MACROGLOBULIN AND C1-INHIBITOR LEVELS IN RENAL ALLOGRAFT RECIPIENTS DURING IMMUNOSUPPRESSION WITH CYCLOSPORIN A
47. Controlled Multicenter Pilot Study of Urokinase – Heparin and Streptokinase in Deep Vein Thrombosis
48. Influence of heparin cofactor II (HCII) on the determination of antithrombin III (AT)
49. Purification and Partial Characterization of a Hereditary Abnormal Antithrombin III Fraction of a Patient with Recurrent Thrombophlebitis
50. Control of Heparin Treatment with three Different Methods. Behaviour of Antithrombin III
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.